Blog
How do you value Home Trial Support? Part 4: Speed, and the evidence we did not have in 2020
How do you value Home Trial Support? Part 3: Retention and the cost of waiting
How do You value Home Trial Support? Part 2: Putting the patient first and researching in the home
How do you value Home Trial Support? Part 1: Site fragility and why it never went away
The $20 Million advantage: What decentralised trials are really worth
Bringing an ALS trial home – How far can you actually go?
Bringing a Duchenne trial home – How far can you actually go?
Beyond home visits: A site perspective on the future of DCT
Unlocking rare disease research: What the MHRA’s draft framework means for DCT
How to stop clinical trials failing before they start